PKU monitoring – phenylalanine and tyrosine
- Description
- Analysis of the amino acids phenylalanine (phe) and tyrosine (tyr) by liquid chromatography-tandem mass spectrometry.
- Clinical details
For monitoring patients with known inherited metabolic disease affecting phenylalanine and tyrosine metabolism, including phenylketonuria (PKU) and tyrosinaemia.
- Related condition
- Reference range
As a guide, for patients with phenylketonuria on diet, the target ranges are:
0 – 12 years 120-360 µmol/L
>12 years 120-600 µmol/L
In pregnancy 120-300 µmol/L
- Units
umol/L
- Synonyms
PKU, Phenylalanine, Tyrosine, Metabolic, Phe, PKU Mon, Phenylketonuria
- Testing site
- Synnovis : Reference Services : Blackfriars Hub
- Laboratory
- Inherited Metabolic Disease
- Sample type and volume required
Bloodspot card. Minimum two >7 mm diameter bloodspots.
Blood must be soaked through. Bloodspots should NOT be multi-spotted, compressed or creased.
Samples should be received into the laboratory within 14 days of collection
- Special sample instructions
Guthrie cards are the same as used for the National Newborn Screening Programme. Please ensure bloodspot cards are clearly labelled requesting either PKU monitoring or Tyrosinaemia analysis as appropriate
- Storage and transport
Send via first class post
- Turnaround time
Same day if received by 10am (Mon-Fri)
- Contacts
Inherited Metabolic Diseases Unit at Blackfriars Hub
IMD Duty Biochemist: 07592 502653
Email: ClinicalScientistIMD@synnovis.co.uk
Reference Chemistry
Floor 1, Synnovis hub
Friars Bridge Court
41-43 Blackfriars Road
London
SE1 8NZ
